Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Operating Leases (2019 - 2025)

Macrogenics (MGNX) has disclosed Operating Leases for 7 consecutive years, with $36.8 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 12.78% to $36.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.8 million through Dec 2025, up 12.78% year-over-year, with the annual reading at $36.8 million for FY2025, 12.78% up from the prior year.
  • Operating Leases for Q4 2025 was $36.8 million at Macrogenics, up from $31.9 million in the prior quarter.
  • The five-year high for Operating Leases was $36.8 million in Q4 2025, with the low at $17.0 million in Q3 2022.
  • Average Operating Leases over 5 years is $27.5 million, with a median of $30.0 million recorded in 2022.
  • The sharpest move saw Operating Leases dropped 22.81% in 2022, then surged 77.54% in 2023.
  • Over 5 years, Operating Leases stood at $20.8 million in 2021, then soared by 44.8% to $30.1 million in 2022, then grew by 0.3% to $30.2 million in 2023, then rose by 7.95% to $32.6 million in 2024, then rose by 12.78% to $36.8 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $36.8 million, $31.9 million, and $32.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.